Announced Thu, 28 May · 20:55 IST

The Board of Directors in their meeting held on today i.e., Thursday, May 28, 2026, approved the Audited Standalone and Consolidated Financial Results of the Company for the half-year and ....

Revenue Growth 20pctPat NegativeEbitda Margin CompressionNegative Operating CashflowDebt Equity ThresholdRelated Party TransactionsResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+9.8%1-day move
₹62.00
prior close
₹59.02
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.8+22.0+22.0+22.0+9.8+6.1+1.5-6.5+8.1-11.3
Up moveDown movePending
AI summary

Valencia Nutrition Ltd reported audited standalone revenue from operations of Rs. 847.09 Lakhs for FY26, up 27.6% from Rs. 663.64 Lakhs in FY25. However, standalone profit after tax declined slightly to Rs. 103.72 Lakhs from Rs. 107.41 Lakhs. On consolidated basis, revenue from operations was Rs. 787.83 Lakhs (down from Rs. 847.09 Lakhs), with consolidated PAT at Rs. 109.27 Lakhs. EPS improved significantly to Rs. 1.78 (standalone) and Rs. 1.88 (consolidated) from Rs. 0.77 previously. The company received an unmodified audit opinion from HAY & Associates LLP. The Board also noted a non-compliance notice from the Exchange, with penalties paid and internal compliance mechanisms strengthened. During the year, the company incorporated new subsidiaries including Valencia Cielo Libre Beverages (Spain) and Valencia Nutracare Lifesciences. Long-term borrowings increased significantly from Rs. 148.67 Lakhs to Rs. 1,513.29 Lakhs on consolidated basis.

Likely market impact

Revenue growth on standalone basis is positive, but consolidated revenue decline and flat profit growth suggest mixed performance. The significant increase in debt levels and negative operating cash flow of Rs. 819.38 Lakhs (consolidated) indicate the company is in aggressive investment mode, which may concern risk-averse investors. The clean audit opinion and compliance resolution are reassuring.